Global Qualitative Analysis Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Research Report 2018 adds “Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2018-2022” new report to its research database. The report spread across 111 pages with table and figures in it.


About Enzyme-linked Immunosorbent Assay (Elisa) Testing

Enzyme-linked immunosorbent assay (ELISA) is mainly used to measure antibodies, antigens, proteins, and glycoproteins in biological samples.


Research analysts forecast the global enzyme-linked immunosorbent assay (Elisa) testing market will register a revenue of more than USD 560 million by 2022.


Covered in this report

The report covers the present scenario and the growth prospects of the global enzyme-linked immunosorbent assay (Elisa) testing market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.


Browse full table of contents and data tables at


The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA


Research report, Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Research recognizes the following companies as the key players in the global enzyme-linked immunosorbent assay (Elisa) testing market: Abcam, BD, bioMérieux, Bio-Rad Laboratories, and Thermo Fisher Scientific.


Commenting on the report, an analyst from Research team said: “One trend in the market is increasing cases of cancer. The increasing incidences of cancer is one of the key trends that will gain traction in the enzyme-linked immunosorbent assay (ELISA) testing market during the next few years. Owing to factors such as unhealthy diet, lack of physical activity, tobacco use, and excessive consumption of alcohol, there is an increase in the prevalence of cancer.


Order a Purchase Report Copy at


According to the report, one driver in the market is growing need for frequent testing among the aging population. According to the world bank, there is a considerable increase in the older population (65 years and above) and this population account for more than 8% of the global population. This population is prone to several types of communicable and non-communicable diseases such as cardiovascular disease, lung disease, and cancer, which drives the demand for the prevention, diagnosis, and treatment of such diseases.


Further, the report states that one challenge in the market is lack of accessibility and affordability of diagnostic tests in developing countries. High-quality diagnostic tests are easily available for various diseases in majority of these developed countries. However, they are neither affordable nor accessible in developing countries where disease burden is high.


The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.


Key questions answered in this report


– What will the market size be in 2022 and what will the growth rate be?

– What are the key market trends?

– What is driving this market?

– What are the challenges to market growth?

– Who are the key vendors in this market space?


Enquiry before Buying at


About: is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on industries, organizations, products, and trends.



Mr. Jeet Jain

Sales Manager



Connect with us:  Google+ | LinkedIn | Twitter | Facebook


View all posts by →